Oral and Poster Presentation Awards – Agar Art Award
- Best Short Oral Presentation in the Parallel Session “Section A – General Microbiology” – 100 € – Katy Poncin
- Best Short Oral Presentation in the Parallel Session “Section B – Applied and Environmental Microbiology” – 100 € – Lucas Henrion lucas.henrion@ULiège.be
- Best Short Oral Presentation in the Parallel Session “Section C – Host-Microbe Interactions” – 100 € (two ex aequo winners) – Yoann Santin and Jad Atrissi
- Best Poster Presentation in “Section A – General Microbiology” – this prize is sponsored by ASM: one ASM membership and one ASM e-book with a value up to $ 150 – Hans Carolus
- Best Poster Presentation in “Section B – Applied and Environmental Microbiology” – this prize is sponsored by BCCM (Belspo) – 150 € – Josefien Van Landuyt
- Best Poster Presentation in “Section C – Host-Microbe Interactions” – 150 € – Irina Spacova
- Prize for the Best Agar Art – Bol.com voucher of 50 € – Anne-Sofie De Rop
Date and location
Date: February 10, 2023
Venue: VUB Aula Q, Pleinlaan 2, Brussels, Belgium
Invited speakers

Tessa Quax
Infection mechanisms of haloarchaeal viruses
Viruses by far outnumber cells and there is an ongoing arms race for survival. Archaea are ubiquitous microorganisms that form a separate domain of life. Archaea are infected by unusual viruses that are structurally very diverse and include those with unique capsid shapes such as a bottle, and viruses with cosmopolitan morphologies, such as head-tailed viruses. As the archaeal cell envelope is fundamentally different from that of bacteria and archaea, archaeal viruses face different challenges when traversing the cell envelope on their way in and out of the cell. We use haloarchaea and their viruses to study viral infection mechanisms. In contrast to other Haloferax strains, Haloferax gibbonsii LR2-5 is very susceptible to viral infection and serves as a host for a dozen of viruses. In my talk, I will present our current understanding of the mechanism of viral entry in this achaeon.

Rut Carballido-Lopez
Shaping the bacterial cell wall: actin-like MreB proteins, from single molecules to cell morphogenesis
How cells control their shape is a long-standing question in cell biology. In bacteria, the external peptidoglycan cell wall -one of the most prominent targets for antibiotics- is the primary determinant of cell shape. Many rod-shaped bacteria elongate their sidewalls by the action of cell wall synthesizing machineries that are associated to circumferentially-moving actin-like MreB nanofilaments. The prevailing model is that MreB assemblies are used as platforms that restrict the diffusion and orient the motion of peptidoglycan-synthesizing enzymes in the membrane, thereby patterning new cell wall insertion. Our lab uses cutting-edge fluorescence microscopy techniques combined with automated single particle and single molecule tracking to visualize MreB isoforms, as a proxy for cell wall synthesis, in live cells of the model Gram-positive bacterium Bacillus subtilis. We are also using super-resolution techniques to elucidate the nanostructure and orientation of MreB cortical assemblies in the cell. In parallel, we are investigating the biochemical and polymerization properties of recombinant MreB in vitro to fill in the gap between structure and cellular function of MreB filaments. Based on our results, we have recently proposed a model for the mechanism of MreB polymerization, which displays some unexpected actin-unlike properties.

Frederik Hammes
Legionella in complex biofilms: collaborators and antagonists within the building plumbing microbiome
Building plumbing systems are engineered aquatic environments where complex biofilms establish and evolve. Opportunistic pathogenic bacteria including many Legionella species colonise and proliferate within these biofilm communities, thereby diminishing the hygienic quality of the water. This talk will explore the ecological interactions between Legionella and the surrounding prokaryotic and eukaryotic microbiome – relative to prevailing environmental conditions. The goal is to better understand the microbial ecology of these organisms, and ultimately use that knowledge to control unwanted Legionella growth in buildings.

Martin Picard
Elucidating energy coupling of tripartite transport machineries from Gram negative bacteria in biomimetic environments
The need to overcome antibiotic resistance in common Gram-negative pathogens remains unmet and represents a challenging aspect of the research in the field of antimicrobials. Among the various resistance mechanisms developed by bacteria, efflux pumps are on the front line. They consist of membrane proteins that expel noxious compounds outside of the bacteria, across its two-membranes environment. Efflux pumps constitute promising therapeutic targets, as their blockage could restore the actual arsenal utility. We have developped an original and unique methodology that allows to specifically monitor the activity of in vitro reconstituted efflux pumps from Gram negative bacteria. This test relies on the reconstitution of the efflux pumps in proteoliposomes mimicking the two-membranes architecture of the envelope of Gram-negative bacteria, and on the monitoring of the transfer of substrates through the reconstituted pump using fluorescent reporters. Our in vitro approach allows us to study the molecular determinants behind efflux pump assembly and transport and to tackle their structure-function analysis by crystallography, cryo-EM and NMR. In addition, the methodology was miniaturized and automatized on a 96-wells microplate reader, hence making it possible to automatically test large-scale chemical libraries. Our project is to identify efflux pump inhibitors (EPI) that consist of adjuvant molecules without intrinsic antibiotic activity but working by blocking efflux pump and therefore restoring the activity of antibiotics.
BSM Honorary Lecture

Jeroen Raes
Quantitative microbiome profiling in health and disease
Alterations in the gut microbiota have been linked to various pathologies, ranging from inflammatory bowel diseases and diabetes to cancer.
Although large numbers of clinical studies aiming at microbiome-based disease markers are currently being performed, our basic knowledge about the normal variability of the human intestinal microbiota and its determining factors remains limited. Here, I will discuss our findings studying a large-scale study (Flemish Gut Flora Project; n=3400) of the gut microbiome variation in a geographically confined region (Flanders, Belgium), in which analysis of microbiome variability in health identified the primary parameters associated to microbiome composition. In this presentation, I will discuss our experiences in large-scale microbiome monitoring, show how the development of dedicated computational approaches can assist in microbiome analysis and interpretation, and which confounders are essential for inclusion in microbiome disease research.
In addition, I will show how Quantitative Microbiome Profiling (QMP; Vandeputte et al. Nature 2017), which combines microbiomics with flow cytometry-based cell counts, is profoundly changing our view on gut microbiota variation and allowed the identification of an inflammation-associated, cross-disease enterotype. Leads from such QMP-based profiling are enabling the development of microbiome modulation strategies.


Gold Sponsors



Register for the event – closing date 3 Feb
BSM member discount (Ticket at 0 euro) is only available when your have an active 2023 membership.
